To celebrate the Open Access Week 2012, MyScienceWork in partnership with UNESCO and UPMC organize for the first time in Paris, two events dedicated to Open Access. Discover here the presentation of Nathalie Duchange (INSERM)

1. Open Access
in the biomedical field
The rise of PLoS ONE
Nathalie Duchange
Inserm
October 25, 2012

2. International movement
born in the 1990s
to allow the free dissemination
of publicly-funded research

3. TWO GREEN
COMPLEMENTARY OPEN REPOSITORIES
ROUTES (institutional and disciplinary)
Authors self-archive their
scientific output
GOLD
AUTHOR-PAY TO PUBLISH- MODEL
(Journals that provide OA)
Articles are free to read, share,
distribute, results may be re-used
(authors keep their rights)

4. Specificities of the biomedical field that
impact on both routes to Open Access

5. Central role of publication
1 « Publish or Perish »
Evaluation is based on
publication in high quality
peer-reviewed journals
Journals’ quality is measured
by the impact factor
Impact: open repositories in life sicences
collect mainly published articles

6. Conditions for archiving in Open Repositories
depend on publishers and the extent
of authors’rights transferred

7. A free open repository of biomedical and life sciences
journal literature: PubMed Central
2 Launched in 2000 by the U.S.
National Institutes of Health's
National Library of Medicine Direct access to the article
(NIH/NLM) from PubMed
(free ressource of citations)
Impact: a reference in the field

8. Network : PubMed Central International
UK PubMed Central to become
Europe PubMed Central in november 2012
www.ebi.ac.uk/Information/News/press-releases/press-release-13072012-Europe_PMC.html

9. From HAL to PubMed Central
Entry by dedicated
HAL is the French national portals, either
multi-diciplinary and institutional,
multi-institutional disciplinary or HAL-Inserm is the institutional
Open Repository thematic portal for Inserm
Part of HAL biomedical articles are transferred to PubMed Central
(Depending on the publishers)

10. Gold Route
The rise of Open Access Journals since 2000

11. What full
Open Access
means ?
http://www.arl.org/sparc/bm~doc/howopenisit_open-review.pdf

12. PLoS: an Open Access Publisher
Public Library of Science is a non profit
publisher founded by leading scientists
7 high impact factor journals
PLoS Biology, PLoS Computational Biology, PLoS
Genetics, PLoS Medicine, PLoS Neglected Tropical
Diseases. PLoS One, PLoS Pathogens.
Revolution in the publishing model:
introducing PLoS One

13. “Peer review is ostensibly one of the central pillars of
modern science. A paper is not taken seriously by
other scientists unless it is published in a “peer
PLoS ONE reviewed” journal.”
“But the truth is that peer review as practiced in the
Revisiting 21st century biomedical research poisons science. It is
Peer-Review conservative, cumbersome, capricious and intrusive.”
Michael Eisen, co-funder of PLoS
www.michaeleisen.org/blog/?p=694
PLoS ONE Peer Review:
- Papers have to be technically sound
- Importance of the paper is let to the readearship

14. Acceptance rate: 70%
Impact Factor > 4
Fast publication
Received: July 12, 2012; Accepted: September 14, 2012; Published: October 17, 2012
Metrics
PLoS ONE
Attractivity for
researchers

15. Will Open Access publishing kill quality?
« Both scientists recently published in a PLOS open
access journal with papers related to the research for
which they were recognized by the Nobel Committee »
« Since 2009, Shinya Yamanaka has published
9 papers in PLOS ONE »
http://blogs.plos.org/blog/2012/10/08/two-plos-authors-awarded-nobel-prize-in-medicine/

16. Conclusion
Opt for Green + Gold
Most research organisations and funders have established
OA mandates and/or policies that support both routes
Gold OA accounts for approximatively
10% of the published articles
The pay-to-publish model is
not without financial risk

17. “The greatest benefit of open
access publishing is widening
the debate on scientific
research; what's free to read
and republish is also free to
discuss, dispute, and learn
from”
Kamran Abbasi
J R Soc Med. 2012 May; 105(5): 185.

18. To learn more

19. Thank you for your attention
?